LMDP10
LMDP10 is an orally active 3-aminoquinazoline derivative that activates the Keap1-Nrf2 pathway. It binds to Keap1, inhibiting the Keap1-Nrf2 interaction and subsequently activating the Nrf2 pathway. This leads to increased levels of Nrf2, SOD, and GSH, while reducing MDA and TNF-α levels. As a result, LMDP10 alleviates neurodegeneration and improves memory in Alzheimer's disease (AD) rat models. LMDP10 is applicable for Alzheimer's disease (AD) research.
Product Specifications
CAS Number
2760446-25-9
Smiles
O=C (NN1C (=O) C=2C=CC=CC2N=C1CN (C3=CC=C (F) C=C3) C (=O) C=4C=CC=CC4) C=5C=CC=CC5
Molecular Formula
C29H21FN4O3
Molecular Weight
492.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
M03500-1 100 µL
Anti-SULT1A1 Mouse Monoclonal Antibody [Clone ID: OTI9B7]
Sign In for Pricing
View Details 46776151 3x 1.0 µg DNA
TLR2 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Sign In for Pricing
View Details